<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>10</volume><submitter>Keiffer G</submitter><journal>Frontiers in oncology</journal><pagination>562219</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7783448</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Upfront Treatment of FLT3-Mutated AML: A Look Back at the RATIFY Trial and Beyond.</pubmed_title><pmcid>PMC7783448</pmcid><pubmed_authors>Palmisiano ND</pubmed_authors><pubmed_authors>Aderhold KL</pubmed_authors><pubmed_authors>Keiffer G</pubmed_authors></additional><is_claimable>false</is_claimable><name>Upfront Treatment of FLT3-Mutated AML: A Look Back at the RATIFY Trial and Beyond.</name><description/><dates><release>2020-01-01T00:00:00Z</release><publication>2020</publication><modification>2025-04-04T07:16:13.629Z</modification><creation>2025-04-04T07:16:13.629Z</creation></dates><accession>S-EPMC7783448</accession><cross_references><pubmed>33415071</pubmed><doi>10.3389/fonc.2020.562219</doi></cross_references></HashMap>